As of 2026-10-07, the EV/EBITDA ratio of Apyx Medical Corp (APYX) is -43.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apyx's latest enterprise value is 114.39 mil USD. Apyx's TTM EBITDA according to its financial statements is -2.62 mil USD. Dividing these 2 quantities gives us the above Apyx EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 16.2x | 14.5x |
| Forward P/E multiples | 17.6x - 20.5x | 18.8x |
| Fair Price | (1.29) - (1.20) | (1.23) |
| Upside | -150.6% - -147.0% | -148.2% |
| Date | EV/EBITDA |
| 2026-10-05 | -44.46 |
| 2026-10-02 | -43.66 |
| 2026-10-01 | -42.86 |
| 2026-09-30 | -42.06 |
| 2026-09-29 | -44.46 |
| 2026-09-28 | -42.86 |
| 2026-09-25 | -50.20 |
| 2026-09-24 | -48.13 |
| 2026-09-23 | -50.05 |
| 2026-09-22 | -50.05 |
| 2026-09-21 | -49.41 |
| 2026-09-18 | -51.80 |
| 2026-09-17 | -51.32 |
| 2026-09-16 | -51.00 |
| 2026-09-15 | -50.20 |
| 2026-09-14 | -51.16 |
| 2026-09-11 | -49.25 |
| 2026-09-10 | -49.09 |
| 2026-09-09 | -51.64 |
| 2026-09-08 | -51.64 |
| 2026-09-04 | -51.64 |
| 2026-09-03 | -51.80 |
| 2026-09-02 | -52.12 |
| 2026-09-01 | -51.64 |
| 2026-08-31 | -51.64 |
| 2026-08-28 | -52.12 |
| 2026-08-27 | -50.84 |
| 2026-08-26 | -51.64 |
| 2026-08-25 | -52.60 |
| 2026-08-24 | -52.12 |
| 2026-08-21 | -52.76 |
| 2026-08-20 | -51.32 |
| 2026-08-19 | -53.24 |
| 2026-08-18 | -52.60 |
| 2026-08-17 | -51.80 |
| 2026-08-14 | -51.32 |
| 2026-08-13 | -51.48 |
| 2026-08-12 | -50.68 |
| 2026-08-11 | -51.16 |
| 2026-08-10 | -58.19 |
| 2026-08-07 | -67.61 |
| 2026-08-06 | -69.36 |
| 2026-08-05 | -69.04 |
| 2026-08-04 | -71.28 |
| 2026-08-03 | -69.68 |
| 2026-07-31 | -68.41 |
| 2026-07-30 | -68.73 |
| 2026-07-29 | -64.25 |
| 2026-07-28 | -64.57 |
| 2026-07-27 | -65.05 |